Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
48
ARGX Quote, Financials, Valuation and Earnings
Last price:
$848.48
Seasonality move
:
0.99%
Day range:
$844.75 - $858.80
52-week range:
$510.06 - $934.62
Dividend yield:
0%
P/E ratio:
43.13x
P/S ratio:
18.10x
P/B ratio:
6.40x
Volume:
250.2K
Avg. volume:
340.6K
1-year change:
34.91%
Market cap:
$52.2B
Revenue:
$2.2B
EPS (TTM):
$21.30
Analysts' Opinion
-
Consensus Ratingargenx SE has received a consensus rating of Buy. The company's average rating is a Buy based on 15 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $1,010.28, argenx SE has an estimated upside of 19.38% from its current price of $849.95.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $660.42 representing 100% downside risk from its current price of $849.95.
Fair Value
-
According to the consensus of 17 analysts, argenx SE has 19.38% upside to fair value with a price target of $1,010.28 per share.
ARGX vs. S&P 500
-
Over the past 5 trading days, argenx SE has underperformed the S&P 500 by -2.04% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
argenx SE does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
argenx SE has grown year-over-year revenues for 12 quarters straight. In the most recent quarter argenx SE reported revenues of $948M.
Earnings Growth
-
argenx SE has grown year-over-year earnings for 0 quarters straight. In the most recent quarter argenx SE reported earnings per share of $3.74.
Enterprise value:
52B
EV / Invested capital:
--
Price / LTM sales:
18.10x
EV / EBIT:
131.84x
EV / Revenue:
16.99x
PEG ratio (5yr expected):
--
EV / Free cash flow:
116.28x
Price / Operating cash flow:
123.85x
Enterprise value / EBITDA:
124.80x
Gross Profit (TTM):
$2.7B
Return On Assets:
21.14%
Net Income Margin (TTM):
41.88%
Return On Equity:
28.06%
Return On Invested Capital:
24.23%
Operating Margin:
21.5%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Income Statement | ||||||
| Revenue | $803.2M | $1.6B | $3.1B | $474.9M | $948M | |
| Gross Profit | $631.6M | $1.3B | $2.7B | $422.5M | $837.2M | |
| Operating Income | -$565M | -$399.4M | $394.5M | -$43.9M | $203.8M | |
| EBITDA | -$459M | -$287.3M | $416.8M | -$14.4M | $288M | |
| Diluted EPS | -$7.17 | -$3.50 | $19.67 | $0.49 | $3.74 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.9B | $2.9B | $2.7B | $4.3B | $5.8B | |
| Total Assets | $3.2B | $3.2B | $3.2B | $4.8B | $7.2B | |
| Current Liabilities | $244M | $264.6M | $317.8M | $499.6M | $1B | |
| Total Liabilities | $261.1M | $279M | $335.7M | $534.3M | $1.1B | |
| Total Equity | $3B | $3B | $2.9B | $4.3B | $6.1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$619.1M | -$145.5M | $542.7M | -$124.7M | $361.8M | |
| Cash From Investing | $258.8M | -$846.1M | -$276.5M | -$513.8M | $62.3M | |
| Cash From Financing | $102.5M | $1.3B | $313.3M | $40.1M | $73.5M | |
| Free Cash Flow | -$723.4M | -$211.2M | $447.4M | -$147M | $312.8M | |
ARGX
Sector
Market Cap
$52.2B
$28.1M
Price % of 52-Week High
90.78%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
-1.02%
-1.49%
1-Year Price Total Return
34.64%
-17.13%
Beta (5-Year)
0.366
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$851.80
200-day SMA
Buy
Level
$690.13
Bollinger Bands (100)
Buy
Level
711.58 - 881.82
Chaikin Money Flow
Buy
Level
4.3M
20-day SMA
Sell
Level
$882.05
Relative Strength Index (RSI14)
Sell
Level
40.17
ADX Line
Sell
Level
22.11
Williams %R
Buy
Level
-81.7199
50-day SMA
Sell
Level
$869.24
MACD (12, 26)
Sell
Level
-8.27
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
22.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (32.6158)
Buy
CA Score
(Annual)
Level (1.4453)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-4.6111)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Stock Forecast FAQ
In the current month, ARGX has received 15 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ARGX average analyst price target in the past 3 months is $1,010.28.
-
Where Will argenx SE Stock Be In 1 Year?
According to analysts, the consensus estimate is that argenx SE share price will rise to $1,010.28 per share over the next 12 months.
-
What Do Analysts Say About argenx SE?
Analysts are divided on their view about argenx SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that argenx SE is a Sell and believe this share price will drop from its current level to $660.42.
-
What Is argenx SE's Price Target?
The price target for argenx SE over the next 1-year time period is forecast to be $1,010.28 according to 17 Wall Street analysts, 15 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is ARGX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for argenx SE is a Buy. 15 of 17 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ARGX?
You can purchase shares of argenx SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase argenx SE shares.
-
What Is The argenx SE Share Price Today?
argenx SE was last trading at $848.48 per share. This represents the most recent stock quote for argenx SE. Yesterday, argenx SE closed at $849.95 per share.
-
How To Buy argenx SE Stock Online?
In order to purchase argenx SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ARGX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ARGX
Sector
P/E ratio
43.13x
23.89x
PEG ratio
--
-0.01x
P/B ratio
6.40x
1.81x
Price / LTM sales
18.10x
1.59x
Growth Metrics
ARGX
Sector
Revenue growth
99.61%
4.62%
Earnings growth
663.27%
11.06%
Revenue (5-year growth)
94.72%
6.5%
Earnings forecast
$4.11
-$0.21
Profitability
ARGX
Sector
Profitability FY 2024
$2B
$3.6M
Return on invested capital
24.23%
-31.84%
Return on assets
21.14%
-27.96%
Return on equity
28.06%
-37.63%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Jan
29
Balance Sheet
ARGX
Sector
Total cash
$3.9B
$26.4M
Short term investments
$1.9B
$25.7M
Total assets
$6.2B
$76.9M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
